Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has reported beneficial ownership of 8.0% of Ocugen, Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 7.1% of Olema Pharmaceuticals, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.2% in Ondas Holdings Inc. common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 2.3% of OppFi Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of OptimizeRx Corp. common stock.

BlackRock, Inc. has disclosed a beneficial ownership of 8.8% of Liberty Latin America Ltd.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 9,013,741 shares, representing 6.2% of the outstanding common stock of Niocorp Developments Ltd.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 12.7% of Allegiant Travel Company's common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.5% in GeneDx Holdings Corp. Class A Stock, as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.0% in JFrog Ltd., holding over 7.3 million shares.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 26,229,501 shares, representing 16.2% of DXC Technology Co.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6.3% of Eagle Financial Services Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.7% in EyePoint Pharmaceuticals, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.3% of FIGS, Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.9% of First Advantage Corp's common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.6% of First National Corp's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership stake of 5.9% in First United Corp, holding 378,880 shares.

BlackRock, Inc. has reported beneficial ownership of 6.2% of Fossil Group Inc.'s common stock as of June 30, 2026, holding over 3.6 million shares.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 1.3% of Franklin Street Properties Corp. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.1% of Damora Therapeutics Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.9% of Hallador Energy Co.'s common stock as of June 30, 2026.

BlackRock, Inc. has updated its Schedule 13G filing, disclosing beneficial ownership of 1.5% of Health Catalyst, Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.1% in Hycroft Mining Holding Corp. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.5% in Hyperfine Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.3% in Hyperliquid Strategies Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.7% of Immuneering Corp's Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.4% of InfuSystem Holdings, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.9% in Inhibikase Therapeutics Inc. as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.1% of IntelliCheck Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.9% of Intuitive Machines, Inc. Class A Stock as of June 30, 2026.